Biolegend, 100304, Biotin anti-mouse CD3ε Antibody
500microg
Catalog Number: 100304
Loading…
| Verified Reactivity | Mouse |
|---|---|
| Antibody Type | Monoclonal |
| Host Species | Armenian Hamster |
| Immunogen | H-2Kb-specific mouse cytotoxic T lymphocyte clone BM10-37 |
| Formulation | Phosphate-buffered solution, pH 7.2, containing 0.09% sodium azide. |
| Preparation | The antibody was purified by affinity chromatography, and conjugated with biotin under optimal conditions. |
| Concentration | 0.5 mg/ml |
| Storage & Handling | The antibody solution should be stored undiluted between 2°C and 8°C. Do not freeze. |
| Application | FC - Quality testedIHC-F - Verified |
| Recommended Usage | Each lot of this antibody is quality control tested by immunofluorescent staining with flow cytometric analysis. For flow cytometric staining, the suggested use of this reagent is ≤ 0.25 µg per 106 cells in 100 µl. For immunohistochemistry, a concentration range of 5.0 - 10 µg/mL is suggested. It is recommended that the reagent be titrated for optimal performance for each application. |
Unless otherwise stated, the minimum order amount is USD 1,000.
For orders below USD 1,000, an additional handling fee may apply, or we may arrange local delivery / local handover where available.
All quotations are subject to final confirmation, including product availability, lead time, batch information, shipping cost, and applicable export or handling requirements.
For quotation requests, please send an RFQ from website or contact:
Please send inquiries directly to us in the “To” field. Emails sent via BCC, mass mailing, or with unrelated recipients may be automatically filtered and will not be processed.
| Application Notes |
|---|
| Clone 145-2C11 is useful for in vitro blocking of target-specific CTL-mediated cell lysis1, as well as T cell activation assays, inducing proliferation and cytokine production1,2,7,12,16. It also induces apoptosis in immature thymocytes32, and in vivo T cell depletion8-10. Additional reported applications (for relevant formats of this clone) include: immunoprecipitation1, immunohistochemical staining14,15 of acetone-fixed frozen sections and zinc-fixed paraffin-embedded sections, Western blotting4, complement-mediated cytotoxicity6, in vitro and in vivo stimulation of T cells1,2,7,12,16, immunofluorescent staining5, and in vivo T cell depletion8-10. The 145-2C11 antibody has been reported to block the binding of 17A2 antibody to CD3 epsilon-specific T cells11. Clone 145-2C11 is not recommended for formalin-fixed paraffin embedded sections. The LEAF™ purified antibody (Endotoxin <0.1 EU/µg, Azide-Free, 0.2 µm filtered) is recommended for functional assays (Cat. No. 100314). For in vivo studies or highly sensitive assays, we recommend Ultra-LEAF™ purified antibody (Cat. No. 100340) with a lower endotoxin limit than standard LEAF™ purified antibodies (Endotoxin <0.01 EU/µg). |
| Application References(PubMed link indicates BioLegend citation) | Leo O, et al. 1987. P. Natl. Acad. Sci. USA 84:1374. (IP, Activ, Block) Kruisbeek AM, et al. 1991. In Current Protocols in Immunology. 3.12.1. (Activ) Duke RC, et al. 1995. Current Protocols in Immunology. 3.17.1. Salvadori S, et al. 1994. J. Immunol. 153:5176. (WB) Payer E, et al. 1991. J. Immunol. 146:2536. (IF) Jacobs H, et al. 1994. Eur. J. Immunol. 24:934. (CMCD) Vossen ACTM, et al. 1995. Eur. J. Immunol. 25:1492. (Activ) Henrickson M, et al. 1995. Transplantation 60:828. (Deplete) Kinnaert P, et al. 1996. Transpl. Int. 9:386. (Deplete) Han WR, et al. 1999. Transpl. Immunol. 7:207. (Deplete) Miescher GC, et al. 1989. Immunol. Lett. 23:113. (Block) Terrazas LI, et al. 2005. Intl. J. Parasitology. 35:1349. (Activ) Ko SY, et al. 2005. J. Immunol. 175:3309. Podd BS, et al. 2006. J. Immunol. 176:6532. (IHC-F) Tilley SL, et al. 2007. J. Immunol. 178:3208. (IHC-F) Wang W, et al. 2007. J. Immunol. 178:4885. (Activ) Xiao S, et al. 2007. J. Exp. Med. 204:1691. Chappaz S, et al. 2007. Blood doi:10.1182/blood-2007-02-074245. (FC) PubMed. Curtsinger JM, et al.2005. J. Immunol. 175:4392. PubMed Guo Y, et al. 2008. Blood 112:480. PubMed Kenna TJ, et al. 2008. Blood 111:2091. Perchonock CE, et al. 2007. J. Immunol. 179:1768. PubMed Perchonock GE, et al. 2006. Mol. Cell. Biol. 26:6005. PubMed Kanaya T, et al. 2008. Am. J. Physiol. Gastrointest. Liver Physiol. 295:G273. PubMed de Koning BA, et al. 2006. Int. Immunol. 18:941. PubMed Schulteis RD, et al. 2008. Blood 295:G273. PubMed Qi Q, et al. 2009. Blood 114:564. PubMed Helmersson S, et al. 2013. Am J Pathol. 9440:123. Pubmed Wu S, et al. 2014. Clin Vaccine Immunol. 21:156. PubMed Yan J, et al. 2014. Vaccine. 32:2833. PubMed Guiterrez DA, et al. 2014. Diaebetes. 63:3827. PubMed Shi YF, et al. 1991. J Immunol. 146:3340. (Apop) |
|---|
| Product Citations | Suzuki M, et al. 2015. J Immunol. 195: 1273-1281. PubMed Doisne J, et al. 2015. J Immunol. 195: 3937 - 3945.. PubMed Logan K Smith et al. 2018. Immunity. 48(2):299-312 . PubMed Obi AT, et al. 2023. Sci Rep. 13:3253. PubMed Miyake K, et al. 2023. Nat Commun. 14:2694. PubMed Grigsby SM, et al. 2021. Cancers (Basel). 13:. PubMed Song R, et al. 2022. Immunology. 165:274. PubMed Iberg CA, et al. 2022. Cell Rep. 39:110657. PubMed Merana GR, et al. 2022. Cell Rep. 39:110891. PubMed Gupta S, et al. 2022. Sci Adv. 8:eabn4886. PubMed Koizumi M, et al. 2022. J Biol Chem. 298:102506. PubMed Tomiaki C, et al. 2022. Front Immunol. 13:1014462. PubMed Giannou AD, et al. 2023. Immunity. 56:125. PubMed Gonçalves R, et al. 2023. iScience. 26:105972. PubMed De Giovanni M, et al. 2022. Cell. 185:815. PubMed Davis FM, et al. 2020. J Immunol. 2503:204. PubMed Kim S, et al. 2020. Immunity. 53(4):759-774.e9. PubMed Domingues AF, et al. 2020. Elife. 9:e51754. PubMed Roco JA et al. 2019. Immunity. 51(2):337-350 . PubMed Tanimura N et al. 2018. Developmental cell. 46(5):581-594 . PubMed Schloss MJ, et al. 2022. Nat Immunol. 23:605. PubMed Lin YH, et al. 2021. Front Immunol. 12:626418. PubMed Riether C, et al. 2021. Cell Reports. 34(4):108663. PubMed Giambra V et al. 2018. Cell stem cell. 23(5):714-726 . PubMed Sasse C, et al. 2022. Pathogens. 11:. PubMed de Mingo Pulido , et al. 2021. Immunity. 54(6):1154-1167.e7. PubMed Álvaro de Mingo Pulido et al. 2018. Cancer cell. 33(1):60-74 . PubMed Bowers E, et al. 2018. Nat Med. 24:95. PubMed Klarquist J, et al. 2021. Cell Rep. 36:109591. PubMed Hinterbrandner M, et al. 2021. JCI Insight. 6:e151797. PubMed Lu SX, et al. 2021. Cell. . PubMed Liu X, et al. 2021. eLife. 0.416666666666667. PubMed Li Q et al. 2018. Immunity. 48(2):258-270 . PubMed Mann M, et al. 2018. Cell Rep. 25:2992. PubMed Davis FM, et al. 2019. Arterioscler Thromb Vasc Biol. 39:2353. PubMed Olsson A, et al. 2016. Nature. 10.1038/nature19348. PubMed Lim H, et al. 2015. J Immunol. 195: 5432 - 5439. PubMed Kimball A, et al. 2018. Arterioscler Thromb Vasc Biol. 38:1102. PubMed She L, et al. 2021. JCI Insight. 6:e143509. PubMed Paiva RS, et al. 2021. Eur J Immunol. 51:1968. PubMed Kurkewich J, et al. 2016. PLoS One. 11: 0161468. PubMed Jassinskaja M, et al. 2021. Cell Reports. 34(12):108894. PubMed Paiva RA, et al. 2021. Cell Reports. 35(2):108967. PubMed Köchl R, et al. 2020. Elife. 9:00. PubMed Pearce V, et al. 2015. J Immunol. 195: 3206 - 3217. PubMed Hurrell BP, et al. 2019. Cell Rep. 29:4509. PubMed Kimball AS et al. 2019. Immunity. 51(2):258-271 . PubMed Onodera T, et al. 2019. J Immunol. 203:3282. PubMed Matsumura T et al. 2019. Cell Rep. 27(2):561-571 . PubMed Lopez DA, et al. 2022. Cell Rep. 41:111677. PubMed Kotaki R, et al. 2020. Sci Rep. 10:13554. PubMed Derecka M, et al. 2020. Nat Immunol. 261:21. PubMed Kim O, et al. 2017. Nat Commun. 10.1038/s41467-017-00729-8. PubMed Progatzky F, et al. 2021. Nature. 599:125. PubMed Opejin A, et al. 2020. Cell Reports. 33(8):108424. PubMed Frodermann V, et al. 2019. Nat Med. 25:1761. PubMed , et al. 2021. Eur J Immunol. 51:2708. PubMed Onodera T, et al. 2021. Immunity. 54:2385. PubMed Perez E, et al. 2020. J Immunol. 205:2489. PubMed Trefzer A, et al. 2021. Cell Reports. 34(6):108748. PubMed Blanchard A, et al. 2021. Nat Commun. 12:4693. PubMed Pariser DN, et al. 2021. J Clin Invest. 131:00:00. PubMed Fournier M, Bijl C 2015. Stem Cells Dev. 24: 2413-2422. PubMed Galle-Treger L, et al. 2020. J Allergy Clin Immunol. 145:502. PubMed Galle-Treger L, et al. 2019. Nat Commun. 10:713. PubMed Balzano M et al. 2019. Cell reports. 26(12):3257-3271 . PubMed Goldstein JM et al. 2019. Cell reports. 27(4):1254-1264 . PubMed Wuggenig P, et al. 2020. Commun Biol. 3:130. PubMed Wolf SJ, et al. 2022. JCI Insight. 7:. PubMed Honda H, et al. 2014. J Leukoc Biol. 96:1087. PubMed Liao G, et al. 2010. Int Immunol. 1.096527778. PubMed Zeis P, et al. 2020. Immunity. 53:775. PubMed Kimball AS, et al. 2020. Thromb Haemost. 120:289. PubMed Adachi Y, et al. 2019. Nat Commun. 10:3883. PubMed Nagashima H et al. 2019. Immunity. 51(4):682-695 . PubMed van der Poel CE, et al. 2019. Cell Rep. 29:2745. PubMed Murata T, et al. 2020. Sci Rep. 10:13560. PubMed Koide S, et al. 2022. iScience. 25:103603. PubMed Miyauchi K, et al. 2021. Nat Commun. 12:3789. PubMed Park DS, et al. 2019. PLoS Comput Biol. 15:e1006913. PubMed Yoshida H, et al. 2019. Cell. 176:897. PubMed Mohrin M, et al. 2021. Aging Cell. 20:e13313. PubMed Anderson DA, et al. 2022. J Exp Med. 219:. PubMed Wagner AK, et al. 2022. iScience. 25:105137. PubMed Riedel SS, et al. 2021. Molecular Cell. 81(11):2332-2348.e9. PubMed Lutz J, et al. 2015. Nat Commun. 6: 8575. PubMed Matsuzaki Y, et al. 2015. Biomed Rep. 1: 91 - 97. PubMed Han P, et al. 2020. Sci Adv. 6:eaaz1580. PubMed Luo H, et al. 2019. Cell Rep. 26:945. PubMed Ho K, et al. 2014. Cell Death Dis. 5:1518. PubMed Bieber K, et al. 2016. Sci Rep. 6:38357. PubMed Heyde A, et al. 2021. Cell. 184(5):1348-1361.e22. PubMed Li ZG, et al. 2020. Chin Med J (Engl). 1943:133. PubMed O'Boyle C, et al. 2020. Int J Stroke. 0.746527778. PubMed Bae S, et al. 2021. Cell Reports. 35(11):109264. PubMed Zysset D, et al. 2016. Nat Commun. 7:13151. PubMed Muro R, et al. 2015. PLoS One. 10:119898. PubMed Johnson JL et al. 2018. Immunity. 48(2):243-257 . PubMed Deets KA, et al. 2021. Elife. 10:. PubMed Celias DP, et al. 2022. STAR Protoc. 3:101464. PubMed Davis FM, et al. 2021. J Exp Med. 218:. PubMed |
|---|
| RRID | AB_312668 (BioLegend Cat. No. 100303) AB_312669 (BioLegend Cat. No. 100304) |
|---|
| Structure | Ig superfamily, forms CD3/TCR complex with CD3δ, γ and ζ subunits and TCR (α/β and γ/δ), 20 kD |
|---|
| Distribution | Thymocytes (differentiation dependent), mature T cells, NK-T cells |
|---|
| Function | TCR signal transduction, T cell activation, antigen recognition |
|---|
| Ligand/Receptor | Peptide antigen/MHC-complex |
|---|
| Cell Type | NKT cells, T cells, Thymocytes, Tregs |
|---|
| Biology Area | Immunology |
|---|
| Molecular Family | CD Molecules, TCRs |
|---|
| Antigen References | 1. Barclay A, et al. 1997. The Leukocyte Antigen FactsBook Academic Press. 2. Davis MM. 1990. Annu. Rev. Biochem. 59:475. 3. Weiss A, et al. 1994. Cell 76:263. |
|---|
| Gene ID | 12501 |
|---|
| UniProt | View information about CD3epsilon on UniProt.org |
|---|
| Clone | 145-2C11 |
|---|
| Regulatory Status | RUO |
|---|
| Other Names | CD3ε, T3, CD3 |
|---|
| Isotype | Armenian Hamster IgG |
|---|
